您的位置: 专家智库 > >

国家自然科学基金(30500531)

作品数:4 被引量:12H指数:3
相关作者:马岳峰刘志海李辉更多>>
相关机构:浙江大学医学院附属第二医院杭州市滨江医院更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生生物学农业科学更多>>

文献类型

  • 4篇中文期刊文章

领域

  • 3篇医药卫生
  • 1篇生物学
  • 1篇农业科学

主题

  • 3篇炎症
  • 2篇胆碱能抗炎通...
  • 2篇炎症反
  • 2篇炎症反应
  • 2篇脓毒
  • 2篇脓毒症
  • 1篇胆碱
  • 1篇胆碱酯酶抑制...
  • 1篇性疾病
  • 1篇严重脓毒症
  • 1篇炎症性
  • 1篇炎症性疾病
  • 1篇乙酰
  • 1篇乙酰胆碱
  • 1篇抑制剂
  • 1篇制剂
  • 1篇损伤性
  • 1篇全身
  • 1篇全身性
  • 1篇全身性炎症

机构

  • 3篇浙江大学医学...
  • 2篇杭州市滨江医...

作者

  • 3篇刘志海
  • 3篇马岳峰
  • 1篇李辉

传媒

  • 3篇中华急诊医学...
  • 1篇Chines...

年份

  • 3篇2010
  • 1篇2009
4 条 记 录,以下是 1-4
排序方式:
胆碱酯酶抑制剂用于脓毒症治疗的研究进展被引量:1
2010年
近年来胆碱能抗炎通路的发现为人类攻克脓毒症提供了新的方向[1].通过激活胆碱能抗炎通路达到了抑制各种炎症性疾病的作用,包括通过刺激迷走神经、外周激活烟碱型乙酰胆碱受体α7亚基(α7nAChR)或者中枢激活MI受体[2-6].此外,通过胆碱酯酶抑制剂也可以激活胆碱能抗炎通路,达到抑制炎症介质合成和释放,改善实验性脓毒症动物的预后,对临床脓毒症具有潜在的治疗作用[7].现对胆碱酯酶抑制剂用于脓毒症治疗的相关实验研究做一综述.
李辉刘志海马岳峰
关键词:胆碱酯酶抑制剂脓毒症胆碱能抗炎通路刺激迷走神经炎症性疾病乙酰胆碱
Effect of cholinesterase inhibitor galanthamine on circulating tumor necrosis factor alpha in rats with lipopolysaccharideinduced peritonitis被引量:4
2010年
Background The nervous system, through the vagus nerve and its neurotransmitter acetylcholine, can down-regulate the systemic inflammation in vivo, and recently, a role of brain cholinergic mechanisms in activating this cholinergic anti-inflammatory pathway has been indicated. Galanthamine is a cholinesterase inhibitor and one of the centrally acting cholinergic agents available in clinic. This study aimed to evaluate the effect of galanthamine on circulating tumor necrosis factor alpha (TNF-a) in rats with lipopolysaccharide-induced peritonitis and the possible role of the vagus nerve in the action of galanthamine. Methods Rat models of lipopolysaccharide-induced peritonitis and bilateral cervical vagotomy were produced. In the experiment 1, the rats were randomly divided into control group, peritonitis group, and peritonitis groups treated with three dosages of galanthamine. In the experiment 2, the rats were randomly divided into sham group, sham plus peritonitis group, sham plus peritonitis group treated with galanthamine, vagotomy plus peritonitis group, and vagotomy plus peritonitis group treated with galanthamine. The levels of plasma TNF-α were determined in every group. Results The level of circulating TNF-α was significantly increased in rats after intraperitoneal injection of endotoxin. Galanthamine treatment decreased the level of circulating TNF-α in rats with lipopolysaccharide-induced peritonitis, and there was significant difference compared with rats with lipopolysaccharide-induced peritonitis without treatment. The 3 mg/kg dosage of galanthamine had the most significant inhibition on circulating TNF-α level at all the three tested doses. Galanthamine obviously decreased the TNF-a level in rats with lipopolysaccharide-induced peritonitis with sham operation, but could not decrease the TNF-α level in rats with lipopolysaccharide-induced peritonitis with vagotomy. Conclusion Cholinesterase inhibitor galanthamine has an inhibitory effect on TNF-α release in rats with Iipopolysaccharide-ind
LIU Zhi-hai MA Yue-feng WU Jun-song GAN Jian-xin XU Shao-wen JIANG Guan-yu
关键词:GALANTHAMINE
重视胆碱能抗炎通路的研究被引量:3
2009年
外源性和内源性损伤因子可引起细胞各种各样的损伤性病变,与此同时机体的局部和全身则发生一系列复杂的反应,以限制和消灭损伤因子,清除和吸收坏死组织、细胞,并修复损伤,这就是机体的防御性反应一炎症(inflammation)。炎症是损伤和抗损伤的统一过程。一旦机体自身调节功能失衡,炎症反应失控,则自身破坏远比致病因子直接刺激产生的损伤更加严重。
马岳峰徐正宽刘志海
关键词:胆碱能抗炎通路炎症反应损伤性坏死组织功能失衡
脓毒症抗炎治疗的研究进展被引量:5
2010年
脓毒症是对于感染引起的全身性炎症反应,有细菌存在或有高度可疑感染病灶,是创伤、烧伤、休克、感染等急危重病患者的严重并发症之一,也是诱发脓毒性休克、多器官功能障碍综合征(MODS)的重要原因。脓毒症来势凶猛,病情进展迅速,欧洲国家重症监护患者进展成严重脓毒症即脓毒性休克达55%,住院病死率达48%。我国尚缺乏详细的临床流行病学资料,但据推算,每年我国可能有300万例患者发生脓毒症。因此,脓毒症的治疗研究是目前亟待解决的重大课题。
马岳峰徐正宽刘志海
关键词:严重脓毒症抗炎治疗全身性炎症反应危重病患者感染病灶重症监护患者
共1页<1>
聚类工具0